Zi-Cheng Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zi-Cheng Song has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jia-Jia Hu
School of Nursing, Anhui Medical University , Hefei, Anhui
3 shared publications - Shu-Ting Liu
School of Nursing, Anhui Medical University, Hefei, China
3 shared publications - Wei Zhao
Anhui Medical University
3 shared publications - Xue-Ying Xia
School of Nursing, Anhui Medical University, Hefei, China
3 shared publications - Dong-Qing Ye
Affiliations Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui, China, School of Public Health, Anhui University of Science and Technology, Hefei, Anhui, China
1 shared publication - Hong-Fei Cao
Epidemiology and Biostatistics, School of Public Health, Anhui Medical University , Hefei, Anhui
1 shared publication
Latest Publications
- 24 June 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (11) , 5767-5775
Potential protective role of high Mediterranean diet adherence for systemic lupus erythematosus: mediation by liver and kidney function biomarkers in the UK Biobank cohort
Objectives: Despite advances in the treatment of SLE, the complexity and high mortality of the disease drive the need to explore primary prevention strategies. The Mediterranean diet (MD) has shown benefits for various diseases, but its role in SLE remains controversial, lacking evidence from large prospective studies. This study aims to investigate the association between MD and SLE risk and to analyse the potential mediating role of MD-related biomarkers. Methods: We selected 203 119 participants from the UK Biobank (UKB) who were free of SLE at baseline. Their adherence to the MD was assessed using the Mediterranean Diet Adherence Screener (MEDAS) score. Cox proportional hazards regression models were used to analyse the association between MD and SLE risk. Mediation analysis explored the potential mediating role of specific biomarkers. Results: During a median follow-up of 10.6 years, 127 cases of SLE were observed. Moderate adherence to the MD did not show a significant association with SLE risk. However, high adherence was significantly associated with a reduced risk of SLE (hazard ratio: 0.61; 95% CI, 0.374–0.995). Mediation analysis revealed that this protective effect might be partially mediated by changes in liver and kidney function biomarkers, with mediation proportions ranging from 0.32% to 4.61%. Conclusion: High adherence to the MD is significantly associated with a reduced risk of developing SLE. This beneficial effect may be partially mediated by improvements in liver and kidney function biomarkers, providing a scientific basis for further exploration of dietary interventions in the prevention of SLE.
- 24 June 2025
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (11) , 5767-5775
Potential protective role of high Mediterranean diet adherence for systemic lupus erythematosus: mediation by liver and kidney function biomarkers in the UK Biobank cohort
Objectives: Despite advances in the treatment of SLE, the complexity and high mortality of the disease drive the need to explore primary prevention strategies. The Mediterranean diet (MD) has shown benefits for various diseases, but its role in SLE remains controversial, lacking evidence from large prospective studies. This study aims to investigate the association between MD and SLE risk and to analyse the potential mediating role of MD-related biomarkers. Methods: We selected 203 119 participants from the UK Biobank (UKB) who were free of SLE at baseline. Their adherence to the MD was assessed using the Mediterranean Diet Adherence Screener (MEDAS) score. Cox proportional hazards regression models were used to analyse the association between MD and SLE risk. Mediation analysis explored the potential mediating role of specific biomarkers. Results: During a median follow-up of 10.6 years, 127 cases of SLE were observed. Moderate adherence to the MD did not show a significant association with SLE risk. However, high adherence was significantly associated with a reduced risk of SLE (hazard ratio: 0.61; 95% CI, 0.374–0.995). Mediation analysis revealed that this protective effect might be partially mediated by changes in liver and kidney function biomarkers, with mediation proportions ranging from 0.32% to 4.61%. Conclusion: High adherence to the MD is significantly associated with a reduced risk of developing SLE. This beneficial effect may be partially mediated by improvements in liver and kidney function biomarkers, providing a scientific basis for further exploration of dietary interventions in the prevention of SLE.
- 5 September 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (11) , 3515-3523
In vitro silencing of RIP2 in naive CD4+ T cells from lupus-prone mice promotes pathogenic Th17 cell differentiation
Objective This work aims to investigate whether RIP2 silencing in naive CD4+ T cells from lupus-prone mice impacts Th17 cell activity or differentiation in vitro. Methods Naive CD4+ T cells isolation from MRL/lpr mice's spleens. Three RNA interference target sequences of RIP2 were packaged with lentivirus and transfected into naive CD4+ T cells. The shRIP2 with the highest interference efficiency was selected and transfected into naive CD4+ T cells. Naive CD4+ T cells were cultured under conventional (TGF-β1 and IL-6) and pathogenic (IL-6, IL-23, IL-1β) differentiation environments, respectively. Then, RT-qPCR, Western blot or Flow Cytometry were used for measuring the amounts of RIP2 and IL-17 and the differentiation of Th17 cells in two settings. Results Under the conventional Th17 (cTh17) cell differentiation environment (TGF-β1 and IL-6), RIP2 deficiency is linked to decreased IL-17A levels (1.00 ± 0.03 vs 0.80 ± 0.03) and attenuated cTh17 cell (2.46 ± 0.08 vs 0.78 ± 0.03) differentiation (all, P < 0.05). Under the pathogenic Th17 (pTh17) cell environment (IL-1β, IL-23, IL-6), RIP2 deficiency is linked to elevated IL-17A levels (1.03 ± 0.05 vs 1.63 ± 0.07) and enhanced pTh17 cell (3.69 ± 0.19 vs 5.49 ± 0.10) differentiation (all, P < 0.05). Conclusion Our data suggest that RIP2 inhibition induces preferential differentiation of naive CD4+ T cells to pathogenic Th17 cells, while being able to upregulate IL-17A levels in the context of pTh17 cell differentiation. Our study opens up new research areas to reveal the underlying mechanisms and potential therapeutic targets for the prevention and treatment of SLE patients. Key Points • Silencing of RIP2 in naive CD4+ T cells from lupus-prone mice promotes pathogenic Th17 (pTh17) cell differentiation and IL-17A production under pTh17 cell (IL-1β, IL-23, and IL-6) conditions. • RIP2 deficiency in naive CD4+ T cells reduces conventional Th17 (cTh17) cell differentiation and IL-17A production under cTh17 cell (TGF-β1 and IL-6) conditions. • RIP2-deficient naive CD4+ T cells preferentially differentiate towards pTh17 cells rather than cTh17 cells in vitro. • Inhibition of RIP2 may be involved in the development of SLE via effects on Th17/IL-17.
- 5 September 2024
- Published by Springer Nature in Clinical Rheumatology
- Vol. 43 (11) , 3515-3523
In vitro silencing of RIP2 in naive CD4+ T cells from lupus-prone mice promotes pathogenic Th17 cell differentiation
Objective This work aims to investigate whether RIP2 silencing in naive CD4+ T cells from lupus-prone mice impacts Th17 cell activity or differentiation in vitro. Methods Naive CD4+ T cells isolation from MRL/lpr mice's spleens. Three RNA interference target sequences of RIP2 were packaged with lentivirus and transfected into naive CD4+ T cells. The shRIP2 with the highest interference efficiency was selected and transfected into naive CD4+ T cells. Naive CD4+ T cells were cultured under conventional (TGF-β1 and IL-6) and pathogenic (IL-6, IL-23, IL-1β) differentiation environments, respectively. Then, RT-qPCR, Western blot or Flow Cytometry were used for measuring the amounts of RIP2 and IL-17 and the differentiation of Th17 cells in two settings. Results Under the conventional Th17 (cTh17) cell differentiation environment (TGF-β1 and IL-6), RIP2 deficiency is linked to decreased IL-17A levels (1.00 ± 0.03 vs 0.80 ± 0.03) and attenuated cTh17 cell (2.46 ± 0.08 vs 0.78 ± 0.03) differentiation (all, P < 0.05). Under the pathogenic Th17 (pTh17) cell environment (IL-1β, IL-23, IL-6), RIP2 deficiency is linked to elevated IL-17A levels (1.03 ± 0.05 vs 1.63 ± 0.07) and enhanced pTh17 cell (3.69 ± 0.19 vs 5.49 ± 0.10) differentiation (all, P < 0.05). Conclusion Our data suggest that RIP2 inhibition induces preferential differentiation of naive CD4+ T cells to pathogenic Th17 cells, while being able to upregulate IL-17A levels in the context of pTh17 cell differentiation. Our study opens up new research areas to reveal the underlying mechanisms and potential therapeutic targets for the prevention and treatment of SLE patients. Key Points • Silencing of RIP2 in naive CD4+ T cells from lupus-prone mice promotes pathogenic Th17 (pTh17) cell differentiation and IL-17A production under pTh17 cell (IL-1β, IL-23, and IL-6) conditions. • RIP2 deficiency in naive CD4+ T cells reduces conventional Th17 (cTh17) cell differentiation and IL-17A production under cTh17 cell (TGF-β1 and IL-6) conditions. • RIP2-deficient naive CD4+ T cells preferentially differentiate towards pTh17 cells rather than cTh17 cells in vitro. • Inhibition of RIP2 may be involved in the development of SLE via effects on Th17/IL-17.
- 17 August 2024
- Published by Springer Nature in Rheumatology International
- Vol. 44 (10) , 2147-2157
Current investigation of the high prevalence of sexual dysfunction in female patients with systemic lupus erythematosus: a cross-sectional study
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects women of childbearing age and has been reported to cause sexual dysfunction in women. Although there are articles on sexual function in women with SLE, the number of articles is small, and the factors affecting sexual function in women with SLE are controversial. Based on this, this study aimed to investigate the prevalence of sexual dysfunction in Chinese female SLE patients and to explore the factors that influence it. The study design was a cross-sectional study conducted from December 2023 to April 2024 in the Department of Rheumatology and Immunology of a tertiary hospital in Hefei, Anhui Province. A total of 293 female patients diagnosed with SLE were enrolled using face-to-face questionnaires and online questionnaires. The questionnaire consisted of four parts: general information questionnaire, fatigue severity scale (FSS), depression-anxiety-stress scale (DASS-21), and female sexual functioning index (FSFI) scale. A total of 173 (59.04%) patients had sexual dysfunction, including 251 (85.67%) with decreased libido and 186 (63.46%) with difficulty in sexual arousal. There was a correlation between the patients’ total FSFI scores and age (p = 0.028), marital satisfaction (p < 0.001), own education level (p = 0.008), partner’s education level (p = 0.003), place of residence (p = 0.039), monthly household income (p < 0.001), family financial satisfaction(p < 0.001), menstrual status (p = 0.003), hormone use (p = 0.021),immunosuppressant use (p = 0.042), disease activity (p = 0.016), FSS score (p < 0.001), stress score (p < 0.001), anxiety score (p < 0.001) and depression score (p < 0.001)were correlated. The results of stepwise regression analysis showed that marital satisfaction (b = 2.011, t = 3.797, p < 0.001), monthly household income (b = 0.854, t = 2.316, p = 0.021), menstrual status (b = 1.218, t = 2.350, p = 0.019), fatigue scale score (b = − 0.069, t = − 2.302, p = 0.022), and depression score (b = − 0.117, t = − 2.910, p = 0.004) were the influencing factors of FSFI total score, and the difference was statistically significant. The incidence of sexual dysfunction in Chinese female SLE patients is high, and medical personnel should pay more attention to patients’ sexual problems, to provide theoretical and practical bases for further prevention, treatment, and care of sexual dysfunction in female SLE patients.
- 17 August 2024
- Published by Springer Nature in Rheumatology International
- Vol. 44 (10) , 2147-2157
Current investigation of the high prevalence of sexual dysfunction in female patients with systemic lupus erythematosus: a cross-sectional study
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects women of childbearing age and has been reported to cause sexual dysfunction in women. Although there are articles on sexual function in women with SLE, the number of articles is small, and the factors affecting sexual function in women with SLE are controversial. Based on this, this study aimed to investigate the prevalence of sexual dysfunction in Chinese female SLE patients and to explore the factors that influence it. The study design was a cross-sectional study conducted from December 2023 to April 2024 in the Department of Rheumatology and Immunology of a tertiary hospital in Hefei, Anhui Province. A total of 293 female patients diagnosed with SLE were enrolled using face-to-face questionnaires and online questionnaires. The questionnaire consisted of four parts: general information questionnaire, fatigue severity scale (FSS), depression-anxiety-stress scale (DASS-21), and female sexual functioning index (FSFI) scale. A total of 173 (59.04%) patients had sexual dysfunction, including 251 (85.67%) with decreased libido and 186 (63.46%) with difficulty in sexual arousal. There was a correlation between the patients’ total FSFI scores and age (p = 0.028), marital satisfaction (p < 0.001), own education level (p = 0.008), partner’s education level (p = 0.003), place of residence (p = 0.039), monthly household income (p < 0.001), family financial satisfaction(p < 0.001), menstrual status (p = 0.003), hormone use (p = 0.021),immunosuppressant use (p = 0.042), disease activity (p = 0.016), FSS score (p < 0.001), stress score (p < 0.001), anxiety score (p < 0.001) and depression score (p < 0.001)were correlated. The results of stepwise regression analysis showed that marital satisfaction (b = 2.011, t = 3.797, p < 0.001), monthly household income (b = 0.854, t = 2.316, p = 0.021), menstrual status (b = 1.218, t = 2.350, p = 0.019), fatigue scale score (b = − 0.069, t = − 2.302, p = 0.022), and depression score (b = − 0.117, t = − 2.910, p = 0.004) were the influencing factors of FSFI total score, and the difference was statistically significant. The incidence of sexual dysfunction in Chinese female SLE patients is high, and medical personnel should pay more attention to patients’ sexual problems, to provide theoretical and practical bases for further prevention, treatment, and care of sexual dysfunction in female SLE patients.
- 1 October 1999
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 81 (10) , 82-391
Experimental Acute Hematogenous Osteomyelitis in Mice. II. Influence of Staphylococcus Aureus Infection on T-Cell Immunity
A murine model of acute hematogenous osteomyelitis was used to study the immune response following Staphylococcus aureus infection and to examine the hypothesis that the bacteria may modify T-cell responses due to the production of bacterial enterotoxins with mitogenic or superantigenic activity. Lymphnode T cell-receptor expression was assessed with use of flow cytometry and reverse transcription-polymerase chain reaction techniques, and increased apoptosis (programmed cell death) in T-cell subsets was monitored. The expression and levels of circulating cytokines and T-cell cytokines within tissues surrounding the damaged area of the proximal tibia were also investigated. Analysis of T-cell receptors in experimental osteomyelitis revealed two distinct patterns of T-cell evolution during the disease. Certain T-cell subsets (Vβ2, Vβ3, Vβ9, and Vβ10) were activated and expanded during the first 24 hours after infection; they reached maximum levels 6 days after infection, followed by a return to pre-infection levels. In contrast, other T-cell subsets (Vβ11, Vβ12, Vβ13, Vβ14, and Vβ16) contracted during the first 24 hours after infection, followed by expansion to a maximum level 9 days after infection. Activation and proliferation of T-cell subsets (notably Vβ14 T cells) was followed by apoptosis, suggesting that staphylococcal bone infection caused superantigenic-like effects on the mouse immune system. Analysis of cytokine responses in local tissue revealed that the T-cell cytokines interleukin-2 and interferon-γ showed a late and relatively short activation pattern compared with the inflammatory cytokines interleukin-1, interleukin-6, and tumor necrosis factor-α. The results suggest that Staphylococcus aureus bone infection may undermine the antibacterial immune response through downregulation of T-cell immunity and immune-cytokine production, which could increase the severity of the systemic infection and local osseous destruction that occur with acute hematogenous osteomyelitis.
- 1 October 1999
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 81 (10) , 82-391
Experimental Acute Hematogenous Osteomyelitis in Mice. II. Influence of Staphylococcus Aureus Infection on T-Cell Immunity
A murine model of acute hematogenous osteomyelitis was used to study the immune response following Staphylococcus aureus infection and to examine the hypothesis that the bacteria may modify T-cell responses due to the production of bacterial enterotoxins with mitogenic or superantigenic activity. Lymphnode T cell-receptor expression was assessed with use of flow cytometry and reverse transcription-polymerase chain reaction techniques, and increased apoptosis (programmed cell death) in T-cell subsets was monitored. The expression and levels of circulating cytokines and T-cell cytokines within tissues surrounding the damaged area of the proximal tibia were also investigated. Analysis of T-cell receptors in experimental osteomyelitis revealed two distinct patterns of T-cell evolution during the disease. Certain T-cell subsets (Vβ2, Vβ3, Vβ9, and Vβ10) were activated and expanded during the first 24 hours after infection; they reached maximum levels 6 days after infection, followed by a return to pre-infection levels. In contrast, other T-cell subsets (Vβ11, Vβ12, Vβ13, Vβ14, and Vβ16) contracted during the first 24 hours after infection, followed by expansion to a maximum level 9 days after infection. Activation and proliferation of T-cell subsets (notably Vβ14 T cells) was followed by apoptosis, suggesting that staphylococcal bone infection caused superantigenic-like effects on the mouse immune system. Analysis of cytokine responses in local tissue revealed that the T-cell cytokines interleukin-2 and interferon-γ showed a late and relatively short activation pattern compared with the inflammatory cytokines interleukin-1, interleukin-6, and tumor necrosis factor-α. The results suggest that Staphylococcus aureus bone infection may undermine the antibacterial immune response through downregulation of T-cell immunity and immune-cytokine production, which could increase the severity of the systemic infection and local osseous destruction that occur with acute hematogenous osteomyelitis.